Related Experiment Video
Updated: Apr 18, 2026

Development of New Therapeutic Applications Using Microfluidics
Published on: October 1, 2007
Aging reimagined: Bridging clinical modulation and scientific breakthroughs
Salah Mhamdi1,2, Karim Chamari3,4, Ahmed S BaHammam5,6
1University of Sousse, Faculty of Medicine 'Ibn el Jazzar' of Sousse, Sahloul University Hospital, Department of Anesthesia and Intensive Care, Sousse, Tunisia.
Aging is controllable through scientific breakthroughs and lifestyle changes. Research highlights interventions like cellular reprogramming and targeted therapies, shifting focus to preventive health and longevity.
Area of Science:
- Gerontology and Regenerative Medicine
- Molecular Biology and Genetics
- Metabolic and Inflammatory Diseases
Background:
- Aging is increasingly viewed as a modifiable biological process, not an immutable fate.
- Key aging hallmarks include cellular senescence, epigenetic alterations, and impaired autophagy.
- Inflammaging and metaflammation are linked to accelerated aging, driven by factors like poor sleep, nutrition, and stress.
Purpose of the Study:
- To review current research on controllable aging and identify key intervention pathways.
- To explore scientific milestones and clinical innovations impacting biological age.
- To emphasize the shift towards preventive medicine and the role of lifestyle interventions.
Main Methods:
- Literature review of scientific research on aging control.
- Analysis of studies on telomerase, epigenetic reprogramming, and autophagy.
- Examination of clinical trials and lifestyle interventions for aging modification.
Main Results:
- Discoveries in telomerase, cellular reprogramming, and autophagy offer targets for aging intervention.
- Clinical interventions (e.g., metformin) and lifestyle changes demonstrate modifiable aging markers.
- Emerging therapies (senotherapeutics) and precision medicine tools advance preventive strategies.
Conclusions:
- Aging is a dynamic, intervention- amenable process supported by extensive research.
- Prioritizing aging research, translational initiatives, and public health integration is crucial.
- Addressing ethical and regulatory challenges is necessary for equitable access to longevity interventions.
More Related Videos
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Microorganisms in Medicine and Therapeutics
Preclinical Development: Overview
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

